Rn-Bc Tosin Ola-Weissmann is a passionate advocate and seasoned Registered Nurse, currently serving as the President and Founder of Sickle Cell Warriors Inc. Under her leadership, the organization has emerged as a pivotal force in the fight against sickle cell disease, focusing on education, empowerment,...
Rn-Bc Tosin Ola-Weissmann is a passionate advocate and seasoned Registered Nurse, currently serving as the President and Founder of Sickle Cell Warriors Inc. Under her leadership, the organization has emerged as a pivotal force in the fight against sickle cell disease, focusing on education, empowerment, advocacy, and research. With a robust background in patient navigation and clinical practice, Tosin has dedicated her career to elevating patient care and addressing the unique challenges faced by individuals living with sickle cell disease.
At Sickle Cell Warriors, Tosin spearheads key initiatives aimed at increasing awareness and visibility of sickle cell disease on both local and global platforms. She has developed comprehensive educational programs that empower patients and their families with knowledge about the disease, treatment options, and self-management strategies. These programs not only aim to reduce the stigmatization associated with sickle cell disease but also foster a supportive community for patients and caregivers.
Tosin's expertise extends to case management and clinical trials, where she plays a crucial role in bridging the gap between patients and healthcare providers. Her analytical skills and experience in critical care settings, including ICU and medical-surgical nursing, enhance her ability to advocate effectively for patients' needs. By leveraging her extensive knowledge in medicine and patient education, Tosin is committed to driving impactful research initiatives that aim to improve treatment outcomes and quality of life for those affected by sickle cell disease. Through her unwavering dedication and innovative approach, Rn-Bc Tosin Ola-Weissmann continues to inspire change and cultivate hope within the sickle cell community.
